Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer
Clinical trial NCT06693128 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06693128
- Sponsor
- Ruijin Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-21
- Primary completion
- 2026-05-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.